Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GJ.1.2.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GJ.1.2.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GJ.1.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
GL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GL.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
GL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GL.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GL.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.8.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.8.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.8.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.53EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.53ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.53ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.53EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.53EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used